肝硬化患者肝细胞癌诊断延迟的相关因素
该回顾性研究分析了退伍军人健康管理局2006至2011年655例肝硬化合并肝细胞癌患者,46.9%在警示信号后诊断延迟超过60天。延迟与提供者未遵循指南、采用诊断性影像评估而非仅检测甲胎蛋白、以及无关医疗检查中偶然发现相关。诊断延迟60天及以上与较低死亡率相关(未调整HR 0.57,调整后HR 0.63)。
要点
- 肝硬化患者肝细胞癌诊断延迟超过60天者占46.9%。
- 延迟与提供者未遵循指南(调整OR 4.82)、采用诊断性影像评估而非仅测甲胎蛋白(调整OR 2.63)、无关医疗检查中偶然发现(调整OR 2.26)相关。
- 诊断延迟60天及以上与较低死亡率相关(未调整HR 0.57,调整后HR 0.63)。
核心结论
- 近半数肝硬化退伍军人患者在指南定义的警示信号后肝细胞癌诊断延迟60天及以上。
- 需要干预以改善肝细胞癌警示信号的及时随访和指南遵循,以提高肝细胞癌早期检出。
研究设计与样本
- 回顾性研究,收集并分析退伍军人健康管理局电子健康记录数据。
- 纳入2006年至2011年655例肝硬化并诊断为肝细胞癌的患者。
- 采用多变量逻辑回归模型识别与警示信号后诊断延迟超过60天相关的因素。
- 采用多变量Cox比例风险模型评估诊断延迟对生存的影响,并调整患者和提供者特征。
主要发现
- 655例肝硬化合并肝细胞癌患者中,46.9%在警示信号后诊断延迟超过60天。
- 诊断延迟超过60天与提供者未遵循指南显著相关(调整OR 4.82;95%CI 3.12-7.45)。
- 诊断延迟超过60天与采用诊断性影像评估而非仅检测甲胎蛋白显著相关(调整OR 2.63;95%CI 1.09-6.24)。
- 诊断延迟超过60天与无关医疗检查中偶然发现(相比肝细胞癌相关评估)显著相关(调整OR 2.26;95%CI 1.09-4.67)。
- 诊断延迟60天及以上与较低死亡率相关(未调整HR 0.57;95%CI 0.47-0.68;调整后HR 0.63;95%CI 0.50-0.78)。
关键数值与推荐
- 警示信号定义为根据美国肝病研究学会2005年指南最早可作出肝细胞癌诊断的日期。
- 诊断延迟定义为警示信号后超过60天。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: We examined the frequency of and factors associated with delays in diagnosis of hepatocellular carcinoma (HCC) in a cohort of patients with cirrhosis in the Veterans Health Administration. METHODS: In a retrospective study, we collected and analyzed data from the Veterans Health Administration's electronic health records. We used a multivariate logistic regression model to identify factors associated with a delay in diagnosis of HCC of more than 60 days following a red flag (defined as the earliest date at which a diagnosis of HCC could have been made, based on American Association for the Study of Liver Disease 2005 guidelines). We used multivariate Cox proportional hazards model to evaluate the effects of delayed diagnosis on survival, adjusting for patient and provider characteristics. RESULTS: Among 655 patients with cirrhosis and a diagnosis of HCC from 2006 through 2011, 46.9% had a delay in diagnosis of more than 60 days following a red flag for HCC. Delays in diagnosis for more than 60 days were significantly associated with lack of provider adherence to the guidelines (adjusted odds ratio [OR], 4.82; 95% CI, 3.12-7.45), a diagnostic imaging evaluation instead of only measurement of alfa fetoprotein (adjusted OR, 2.63; 95% CI, 1.09-6.24), and diagnosis as an incidental finding during examination for an unrelated medical problem (compared with an HCC-related assessment) (adjusted OR, 2.26; 95% CI, 1.09-4.67). Diagnostic delays of 60 days or more were associated with lower mortality compared to patients without a delay in diagnosis (unadjusted hazard ratio, 0.57; 95% CI, 0.47-0.68 and adjusted hazard ratio, 0.63; 95% CI, 0.50-0.78). CONCLUSIONS: Nearly half of veterans with cirrhosis have delays in diagnosis of HCC of 60 days or more after a red flag, defined by guidelines. Interventions are needed to improve timely follow-up of red flags for HCC and adherence to guidelines, to increase early detection of HCC.
引用
- Choi DT, Davila JA, Sansgiry S, et al. Factors Associated With Delay of Diagnosis of Hepatocellular Carcinoma in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2020. PMID: 32693047. doi:10.1016/j.cgh.2020.07.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。